Will a Brexit Lead to a “Scotxit” (Scotland leaving the UK)?

By Dr Anders Poulsen

I believe this is likely, in part because of the simple calculus of cost benefit analysis that may favour Scotland leaving the United Kingdom, but in part also because the EU may offer such favourable terms to Scotland to join them, not necessarily because it makes economic sense for the EU to do so, but because punishment is a behavioural phenomenon that we often see in our experiments.  I explain these below.

Continue reading

Advertisements

Where has all the research (money) gone?

By Dr Christa Brunnschweiler

I’ve been following the discussion of the various costs (or benefits) for the UK of leaving the EU for a while now. I follow them as a not entirely disinterested outsider: I am not eligible to vote in the upcoming referendum on 23 June, but I am a citizen of another European country and can expect to be affected by the vote’s outcome.

grunge-european-union-flag

Continue reading

Drug prices post-Brexit – an expensive pill to swallow?

by  Dr Farasat Bokhari

Much has already been written about the potential effects of Brexit on both the British economy as well as the rest of the world, vis-à-vis effects on immigration, employment, wages, inflation, investment, growth and so forth, and by now we know that either the sky is going to fall or it will be like manna falling from the sky.  Definitely one of those two.  Reality however is a bit more nuanced, and what follows may be sector specific and depend on the regulations and terms that are negotiated upon exit.  Post exit, will the UK be on its own in terms of trade agreements with the rest of the world, or will it, like Norway, be able to enjoy benefits of a single market by entering into European Economic Area (EEA)? Not to be gauche, how does it affect the price of my medicines here in the UK?   While the Farage v. Cameron debate rages on, in this blog I give example from just one sector – pharmaceuticals – to discuss how prices of branded drugs, which include new and important therapies, may increase due to various trade agreements post Brexit.

_89912627_cameronfarage

Continue reading

Posh and Brex

By Dr David Hugh-Jones

Like everything in Britain, the Brexit debate is all about class. Riffing off Nancy Mitford’s famous distinction between “U” (posh) and “non-U” (vulgar), Harry Mount in the Sunday Times[1] divided the voters up into “EU” and “non-EU”. There’s the sophisticated, well-travelled, culturally open remainers. Then there’s the salt-of-the-earth Brexiteers, who get regarded a bit like the citizens of Rock Ridge in Blazing Saddles: “just simple farmers. These are people of the land. The common clay of the new West. You know… morons.”

david blog

Continue reading

Refugees’ onwards journey into EU destinations

By Dr Liliana Harding

Escalating international conflict appears to feed relentlessly into migrant flows, accounting now for almost one million asylum seekers in Europe during 2015. Since the war in Syria started in 2011 millions have found asylum in surrounding countries, with the EU experiencing what might be described as a belated mass influx. Some 759,000 refugees have entered the EU during 2015 via the Eastern Mediterranean, mainly after transiting Turkey into Greece. This compares to 50,000 arrivals via a similar route during the previous year.  (See the UNHCR website for the latest numbers.)

Syrian_refugees_strike_in_front_of_Budapest_Keleti_railway_station._Refugee_crisis._Budapest,_Hungary,_Central_Europe,_3_September_2015

Syrian refugees strike in front of Budapest Keleti railway station. 3 September 2015.

Continue reading